INSUBCONTINENT EXCLUSIVE:
Jay Thakkar of Anand Rathi has a buy call on Biocon Ltd
with a target price of Rs 311.0
The current price of Biocon Ltd
Jay Thakkar recommended to keep a stoploss at Rs 296
Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 36126.00 Crore) operating in Pharmaceuticals
key Products/Revenue Segments include Other Operating Revenue which contributed Rs 229.40 Crore to Sales Value (7.95 % of Total Sales),
Waste which contributed Rs 15.10 Crore to Sales Value (0.52 % of Total Sales) and Sale of services which contributed Rs 1.00 Crore to Sales
Value (0.03 % of Total Sales)for the year ending 31-Mar-2019
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 1572.20 Crore, up 7.25 % from last quarter Sales of
Rs 1465.90 Crore and up 19.02 % from last year same quarter Sales of Rs 1321.00 Crore Company has reported net profit after tax of Rs 263.20
Mr.John Shaw, Mr.Daniel M Bradbury, Dr.Vijay Kuchroo, Dr.Jeremy Levin, Prof.Ravi Mazumdar
LLP as its auditoRs As on 30-09-2019, the company has a total of 1,200,000,000 shares outstanding.